Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-30 @ 6:34 PM
Study NCT ID:
NCT01286935
Status:
COMPLETED
Last Update Posted:
2011-01-31
First Post:
2010-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD
Sponsor:
Newron Pharmaceuticals SPA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NW-1015/018/III/2006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr Ravi Anand (Chief Medical Officer)
Old Organization:
Newron Pharmaceuticals S.p.A.